My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 530

    1.

    Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.

    Ryan EA, Imes S, Wallace C.

    Diabetes Care. 2004 May;27(5):1028-32.PMID: 15111515 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.

    [No authors listed]

    Ann Intern Med. 1998 Feb 1;128(3):165-75.PMID: 9454524 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

    Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

    Diabetes Care. 1998 Apr;21(4):574-9.PMID: 9571345 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.

    Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, Weng J.

    Diabetes Care. 2004 Nov;27(11):2597-602.PMID: 15504992 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

    Ilkova H, Glaser B, Tunçkale A, Bagriaçik N, Cerasi E.

    Diabetes Care. 1997 Sep;20(9):1353-6.PMID: 9283777 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

    Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

    Lancet. 2008 May 24;371(9626):1753-60.PMID: 18502299 [PubMed - indexed for MEDLINE]Related articles

    7.

    Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.

    Chen HS, Wu TE, Jap TS, Hsiao LC, Lee SH, Lin HD.

    Diabetes Care. 2008 Oct;31(10):1927-32. Epub 2008 Jun 12.PMID: 18556343 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes.

    Juhl CB, Pørksen N, Pincus SM, Hansen AP, Veldhuis JD, Schmitz O.

    Diabetes. 2001 Aug;50(8):1778-84.PMID: 11473038 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    10.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes]

    Li YB, Zhu HL, Yao B, Huang ZM, Ou XZ, Xiao YB, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2005 Mar 9;85(9):602-5. Chinese. PMID: 15949356 [PubMed - indexed for MEDLINE]Related articles

    12.

    U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

    [No authors listed]

    Diabetes. 1995 Nov;44(11):1249-58. Erratum in: Diabetes 1996 Nov;45(11):1655. PMID: 7589820 [PubMed - indexed for MEDLINE]Related articles

    13.

    United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

    Turner R, Cull C, Holman R.

    Ann Intern Med. 1996 Jan 1;124(1 Pt 2):136-45.PMID: 8554206 [PubMed - indexed for MEDLINE]Related articles

    14.

    Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.

    Vinik A.

    Clin Ther. 2007;29 Spec No:1236-53. Review.PMID: 18046925 [PubMed - indexed for MEDLINE]Related articles

    15.

    Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.

    Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N.

    Diabetes Care. 1996 Dec;19(12):1375-81.PMID: 8941467 [PubMed - indexed for MEDLINE]Related articles

    16.

    Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial.

    Weiss SR, Cheng SL, Kourides IA, Gelfand RA, Landschulz WH; Inhaled Insulin Phase II Study Group.

    Arch Intern Med. 2003 Oct 27;163(19):2277-82.PMID: 14581245 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.

    Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald I, Amiel S.

    Diabetes Care. 1998 Feb;21(2):283-90.PMID: 9539997 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.

    Umpierrez GE, Clark WS, Steen MT.

    Diabetes Care. 1997 Apr;20(4):479-83.PMID: 9096964 [PubMed - indexed for MEDLINE]Related articles

    19.

    One-hour meal tolerance test to assess withdrawal of insulin therapy in overweight patients with type 2 diabetes.

    Kumar D, Luna-Lollie T, Madha S.

    Endocr Pract. 2001 Jul-Aug;7(4):256-61.PMID: 11497476 [PubMed - indexed for MEDLINE]Related articles

    20.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity